Extracorporeal Membrane Oxygenation Machine Market Future Prospects
The global extracorporeal membrane oxygenation machine market size stands at USD 567.82 million in 2024, and it is projected to reach USD 864.73 million by 2032, advancing at a CAGR of 5.52% during 2025–2032. This growth can be attributed to the rising prevalence of cardiac diseases, such as cardiogenic shock; and respiratory conditions, such as chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS).
The Global Initiative for Asthma records 7 million deaths every year owing to air-pollution-associated illnesses, including COPD, lung cancer, and respiratory infections. Similarly, the World Health Organization states that 99% of the world’s population inhales polluted and unhealthy air, which leads to innumerable respiratory and cardiac diseases.
Moreover, technological advancements in the field of healthcare, government initiatives regarding the awareness of such diseases and the merits of ECMO devices, and high R&D spending propel the market.